CHIMERIC THERAPEUTICS LIMITED - Announcements

0.00%

0.3¢

Market Cap $9.747M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CHM +MMX	Avoidance of Agreements with Murchison Metals Ltd	PRICE SENSITIVE	18/03/09	19.18KB	Share
CHM	Response to ASX Query	PRICE SENSITIVE	17/03/09	54.48KB	Share
CHM	Half Year Accounts		16/03/09	393.34KB	Share
CHM	Appointment of Auditor		16/03/09	53.36KB	Share
CHM	Letter to Shareholders		13/03/09	235.06KB	Share
CHM	Reply to ASX Letter dated 9 March 2009		11/03/09	38.36KB	Share
CHM	Response to ASX Query	PRICE SENSITIVE	18/02/09	53.75KB	Share
CHM	Initial Director's Interest Notice		17/02/09	18.12KB	Share
CHM	Appointment of (Joint) Company Secretary		13/02/09	12.13KB	Share
CHM	Notice of General Meeting		13/02/09	215.4KB	Share
CHM +MMX	Chameleon Litigation Update		06/02/09	360.17KB	Share
CHM	Second Quarter Activities and Cashflow Reports	PRICE SENSITIVE	30/01/09	145.5KB	Share
CHM	Response to ASX Letter dated 3 December 2008	PRICE SENSITIVE	04/12/08	61.36KB	Share
CHM	Results of Meeting		01/12/08	140.78KB	Share
CHM	Notice of Annual General Meeting		28/11/08	107.31KB	Share
CHM +MMX	Chameleon Litgation Update		28/11/08	360.4KB	Share
CHM +MMX	Litigation Update		27/11/08	29.98KB	Share

CHM +MMXAvoidance of Agreements with Murchison Metals Ltd
18/03/09	PRICE SENSITIVE	19.18KB	Share
CHMResponse to ASX Query
17/03/09	PRICE SENSITIVE	54.48KB	Share
CHMHalf Year Accounts
16/03/09		393.34KB	Share
CHMAppointment of Auditor
16/03/09		53.36KB	Share
CHMLetter to Shareholders
13/03/09		235.06KB	Share
CHMReply to ASX Letter dated 9 March 2009
11/03/09		38.36KB	Share
CHMResponse to ASX Query
18/02/09	PRICE SENSITIVE	53.75KB	Share
CHMInitial Director's Interest Notice
17/02/09		18.12KB	Share
CHMAppointment of (Joint) Company Secretary
13/02/09		12.13KB	Share
CHMNotice of General Meeting
13/02/09		215.4KB	Share
CHM +MMXChameleon Litigation Update
06/02/09		360.17KB	Share
CHMSecond Quarter Activities and Cashflow Reports
30/01/09	PRICE SENSITIVE	145.5KB	Share
CHMResponse to ASX Letter dated 3 December 2008
04/12/08	PRICE SENSITIVE	61.36KB	Share
CHMResults of Meeting
01/12/08		140.78KB	Share
CHMNotice of Annual General Meeting
28/11/08		107.31KB	Share
CHM +MMXChameleon Litgation Update
28/11/08		360.4KB	Share
CHM +MMXLitigation Update
27/11/08		29.98KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $9.747M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$1.858K	619.3K

Buyers (Bids)

No.	Vol.	Price($)
66	58647032	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	107164382	32

View Market Depth

No.	Vol.	Price($)
63	56847033	0.003
28	24808481	0.002
18	63919000	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	99867122	31
0.005	44186931	30
0.006	20755258	19
0.007	3825018	5
0.008	7200898	3

Last trade - 16.10pm 08/08/2025 (20 minute delay)

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available